Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rubenstein

Showing results (51-60 of 477) with videos related to

Pageof 48
Sort By:
Gastroenterology|June 23, 2012
Oracular guidance on clinical management of early neoplastic Barrett's esophagusRebecca C Fitzgerald, Joel H Rubenstein
Gastrointestinal Endoscopy|June 4, 2005
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studiesJoel H Rubenstein, John M Inadomi
Gastrointestinal Endoscopy|November 6, 2008
Models: do they answer the question?Sameer D Saini, Joel H Rubenstein
Current Opinion in Gastroenterology|June 2, 2023
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future stepsAndrew T Kunzmann, Joel H Rubenstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2010
Barrett's esophagus progressing to cancer: a needle in a haystack?Jason J Lewis, Joel H Rubenstein
Annals of Internal Medicine|September 1, 1992
New directions in the immunology of autoimmune diabetesK C Herold, A H Rubenstein
Israel Journal of Medical Sciences|October 1, 1974
Heterogeneity of circulating insulin and proinsulin in manD L Horwitz, A H Rubenstein
The American Journal of Gastroenterology|December 4, 2009
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinomaJoel H Rubenstein, John M Inadomi
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: moving towards the appropriate use of proton pump inhibitorsJacob E Kurlander, Joel H Rubenstein
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Pageof 48

Showing results (51-60 of 477) with videos related to

Sort By:
Pageof 48
Gastroenterology|June 23, 2012
Oracular guidance on clinical management of early neoplastic Barrett's esophagusRebecca C Fitzgerald, Joel H Rubenstein
Gastrointestinal Endoscopy|June 4, 2005
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studiesJoel H Rubenstein, John M Inadomi
Gastrointestinal Endoscopy|November 6, 2008
Models: do they answer the question?Sameer D Saini, Joel H Rubenstein
Current Opinion in Gastroenterology|June 2, 2023
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future stepsAndrew T Kunzmann, Joel H Rubenstein
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2010
Barrett's esophagus progressing to cancer: a needle in a haystack?Jason J Lewis, Joel H Rubenstein
Annals of Internal Medicine|September 1, 1992
New directions in the immunology of autoimmune diabetesK C Herold, A H Rubenstein
Israel Journal of Medical Sciences|October 1, 1974
Heterogeneity of circulating insulin and proinsulin in manD L Horwitz, A H Rubenstein
The American Journal of Gastroenterology|December 4, 2009
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinomaJoel H Rubenstein, John M Inadomi
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: moving towards the appropriate use of proton pump inhibitorsJacob E Kurlander, Joel H Rubenstein
Diabetes|May 1, 1984
C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitationsK S Polonsky, A H Rubenstein
Pageof 48